Fisher Asset Management LLC has recently announced that it has increased stake in Sanofi ADR (NASDAQ:SNY) by 15.33%. After grabbing 14.94 million shares, the institutional investor is now in possession of 1.99 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.59% having worth around $743.1 million. Moreover, Strategic Advisers LLC increased its share by 0.51 million to have a control over 8.92 million shares. And Managed Account Advisors LLC raised its holdings to 0.16 million shares by acquiring 7.49 million shares or 0.30% of the stake.
Sanofi ADR (SNY) concluded trading on Thursday at a closing price of $49.88, with 2.87 million shares of worth about $143.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.78% during that period and on Thursday, January 25 the price saw a loss of about -0.02%. Currently the company’s common shares owned by public are about 2.51B shares, out of which, 2.51B shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Dodge & Cox Stock Fund, Dodge & Cox Balanced Fund, and John Hancock III – Disciplined Va are the top 3 mutual funds which are holding stakes in Sanofi ADR Dodge & Cox Stock Fund is currently holding 58.21 million shares of worth totaling $2.89 billion. The company recently came selling 94400.0 shares which brought its stake up to 2.30% of the company’s outstanding shares. Dodge & Cox Balanced Fund sold -1.03 million shares, after which its hold over company’s outstanding shares shrunk to 0.20%, leaving 5.03 million shares with the mutual fund that have a worth of about $250.37 million. John Hancock III – Disciplined Va, after buying 4.78 million shares, have now control over 0.19% of the stake in the company. It holds 0.0 shares of worth $237.73 million.
Stock saw a price change of -3.86% in past 5 days and over the past one month there was a price change of 2.34%. Year-to-date (YTD), SNY shares are showing a performance of 0.30% which increased to 2.78% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $42.63 but also hit the highest price of $57.82 during that period. The average intraday trading volume for Sanofi ADR shares is 2.03 million. The stock is currently trading -2.04% below its 20-day simple moving average (SMA20), while that difference is up 2.65% for SMA50 and it goes to -3.86% lower than SMA200.
Fisher Asset Management LLC acquired 14.94 million shares of Sanofi ADR having value of about $743.1 million. Data submitted at the U.S SEC by Fisher Asset Management LLC revealed that the firm now holds 1.99 million shares in the company valued at close to $99099040.12, or have control over 15.33% stake in the company. Sanofi ADR (NASDAQ: SNY) currently have 2.51B outstanding shares and institutions hold larger chunk of about 10.04% of that. Holding of mutual funds in the company is about 4.48% while other institutional holders and individual stake holders have control over 5.45% and — of the stake respectively.
The stock has a current market capitalization of $125.09B and its 3Y-monthly beta is at 0.62. PE ratio of stock for trailing 12 months is 13.99, while it has posted earnings per share of $3.57 in the same period. Its PEG reads 2.81 and has Quick Ratio of 0.81 while making debt-to-equity ratio of 0.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SNY, volatility over the week remained 1.21% while standing at 1.23% over the month.
Analysts are in expectations that Sanofi ADR (SNY) stock would likely to be making an EPS of $1.5 in the current quarter, while forecast for next quarter EPS is $0 and it is $7.47 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.9 which is $1.88 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.87 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -1.97% while it is estimated to decrease by -2.32% in next year. EPS is likely to shrink at an annualized rate of 4.98% for next 5-years, compared to annual growth of 15.72% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on January 23, 2024 offering an Equal-weight rating for the stock and assigned a target price of $55 to it.
